BridgeBio Oncology Therapeutics: principal accounting officer Marc Cobo sold 126 shares

What happened Marc Cobo, the principal accounting officer, had 126 shares withheld by the issuer to satisfy tax withholding obligations in connection with the vesting of restricted stock units. The Form 4 shows 126 shares disposed at $3.94 per share for a total of $496 on Oct 1, 2026 (transaction code F).

Key details

• Transaction date and price: Oct 1, 2026; $3.94 per share; 126 shares; $496 total.
• Transaction code: F (payment of exercise price or tax liability).
• Shares owned after the transaction: not reported in this filing.
• Footnote F1: represents the number of shares withheld by the issuer to satisfy the reporting person’s tax withholding obligations in connection with the vesting of restricted stock units.
• Filing date: Oct 5, 2026 (Form 4 accession 0001193125-26-414135).

Why it may matter This was a tax-withholding transaction related to RSU vesting; the shares were withheld to cover tax obligations rather than sold on the open market. A filing does not show why the insider traded or why the company acted.